$BTAI Announces Addition of Merck KGaA Darmstadt Germany and $PFE to Clinical Collaboration with $NKTR for Development of Triplecombination Therapy in Pancreatic Cancer httpsfinance.yahoo.comnewsbioxceltherapeuticsannouncesadditionmerck13000

$BTAI Announces Addition of Merck KGaA, Darmstadt, Germany, and $PFE to Clinical Collaboration with $NKTR for Development of Triple-combination Therapy in Pancreatic Cancer https://finance.yahoo.com/news/bioxcel-therapeutics-announces-addition-merck-13000

08:07 EST 4 Mar 2019 | Odi Bruckman

$BTAI Announces Addition of Merck KGaA, Darmstadt, Germany, and $PFE to Clinical Collaboration with $NKTR for Development of Triple-combination Therapy in Pancreatic Cancer https://finance.yahoo.com/news/bioxcel-therapeutics-announces-addition-merck-130000705.html …

More From BioPortfolio on "$BTAI Announces Addition of Merck KGaA, Darmstadt, Germany, and $PFE to Clinical Collaboration with $NKTR for Development of Triple-combination Therapy in Pancreatic Cancer https://finance.yahoo.com/news/bioxcel-therapeutics-announces-addition-merck-13000"